Full Press Release Details
dupixent dupilumab u s label updated with data further supporting use in atopic dermatitis with moderate to severe hand and foot involvement.
REGN
dupixent dupilumab u s label updated with data further supporting use in atopic dermatitis with moderate to severe hand and foot involvement
Key Takeaway: dupixent dupilumab u s label updated with data further supporting use in atopic dermatitis with moderate to severe hand and foot involvement